| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.745 | 0.005 | 0.878 | Anticonvulsant | 0.805 0.004 DB14028 0.878 0.004 DBMET00246 0.637 0.005 DBMET00980 | DBMET00246 | |
| 0.627 | 0.005 | 0.807 | GABA C receptor rho-3 antagonist | 0.794 0.002 DB14028 0.668 0.004 DBMET00246 0.807 0.001 DBMET00980 | DBMET00980 | |
| 0.571 | 0.015 | 0.571 | 5 Hydroxytryptamine release inhibitor | 0.419 0.067 DB14028 0.358 0.108 DBMET00246 0.444 0.054 DBMET00980 | ||
| 0.458 | 0.047 | 0.488 | Calcium channel L-type activator | 0.455 0.048 DB14028 0.279 0.175 DBMET00246 0.488 0.032 DBMET00980 | DBMET00980 | |
| 0.351 | 0.029 | 0.354 | Interleukin agonist | 0.354 0.028 DB14028 0.195 0.126 DBMET00246 0.344 0.031 DBMET00980 | DB14028 | |
| 0.326 | 0.005 | 0.326 | ATPase inhibitor | 0.248 0.014 DB14028 0.202 0.036 DBMET00246 0.254 0.013 DBMET00980 | ||
| 0.326 | 0.018 | 0.334 | Gastrin inhibitor | 0.334 0.015 DB14028 0.23 0.104 DBMET00246 0.292 0.039 DBMET00980 | DB14028 | |
| 0.306 | 0.006 | 0.306 | NMDA receptor antagonist | 0.183 0.017 DB14028 0.118 0.036 DBMET00246 0.291 0.007 DBMET00980 | ||
| 0.342 | 0.049 | 0.342 | Interleukin 2 agonist | |||
| 0.294 | 0.004 | 0.667 | Benzodiazepine agonist | 0.601 0.002 DB14028 0.667 0.002 DBMET00246 0.317 0.003 DBMET00980 | DBMET00246 | |
| 0.295 | 0.005 | 0.572 | GABA C receptor rho-2 antagonist | 0.572 0.002 DB14028 0.344 0.004 DBMET00246 0.55 0.002 DBMET00980 | DB14028 | |
| 0.386 | 0.114 | 0.464 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.464 0.052 DB14028 0.38 0.119 DBMET00246 0.345 0.157 DBMET00980 | DB14028 | |
| 0.274 | 0.004 | 0.274 | NMDA receptor agonist | 0.11 0.016 DB14028 0.087 0.025 DBMET00246 0.094 0.021 DBMET00980 | ||
| 0.269 | 0.002 | 0.269 | NMDA receptor glycine site antagonist | 0.065 0.005 DB14028 0.041 0.008 DBMET00246 0.066 0.005 DBMET00980 | ||
| 0.274 | 0.008 | 0.637 | GABA receptor agonist | 0.482 0.004 DB14028 0.637 0.003 DBMET00246 0.387 0.004 DBMET00980 | DBMET00246 | |
| 0.268 | 0.013 | 0.494 | Glutamate receptor antagonist | 0.494 0.004 DB14028 0.174 0.036 DBMET00246 0.441 0.005 DBMET00980 | DB14028 | |
| 0.249 | 0.01 | 0.249 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 DB14028 0.112 0.044 DBMET00246 0.082 0.078 DBMET00980 | ||
| 0.235 | 0.009 | 0.244 | Falcipain 2 inhibitor | 0.244 0.008 DB14028 0.215 0.011 DBMET00980 | DB14028 | |
| 0.235 | 0.009 | 0.243 | Falcipain inhibitor | 0.243 0.008 DB14028 0.216 0.012 DBMET00980 | DB14028 | |
| 0.274 | 0.05 | 0.574 | Psychostimulant | 0.574 0.007 DB14028 0.568 0.007 DBMET00246 0.55 0.008 DBMET00980 | DB14028 | |
| 0.331 | 0.108 | 0.331 | Histamine release inhibitor | 0.238 0.164 DB14028 0.321 0.113 DBMET00980 | ||
| 0.309 | 0.086 | 0.309 | Cholesterol antagonist | |||
| 0.288 | 0.066 | 0.288 | Insulysin inhibitor | 0.23 0.116 DB14028 0.247 0.099 DBMET00980 | ||
| 0.261 | 0.043 | 0.3 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 DB14028 0.25 0.049 DBMET00246 0.3 0.031 DBMET00980 | DBMET00980 | |
| 0.221 | 0.005 | 0.706 | GABA receptor antagonist | 0.66 0.003 DB14028 0.706 0.003 DBMET00246 0.579 0.003 DBMET00980 | DBMET00246 | |
| 0.217 | 0.003 | 0.217 | NMDA receptor glycine site agonist | 0.127 0.007 DB14028 0.108 0.013 DBMET00246 0.11 0.012 DBMET00980 | ||
| 0.214 | 0.004 | 0.214 | NMDA receptor subunit 3B antagonist | 0.126 0.008 DB14028 0.049 0.026 DBMET00246 0.207 0.004 DBMET00980 | ||
| 0.214 | 0.006 | 0.321 | GABA C receptor rho-1 antagonist | 0.321 0.003 DB14028 0.191 0.01 DBMET00246 0.295 0.004 DBMET00980 | DB14028 | |
| 0.215 | 0.01 | 0.469 | GABA C receptor antagonist | 0.469 0.003 DB14028 0.218 0.01 DBMET00246 0.461 0.003 DBMET00980 | DB14028 | |
| 0.206 | 0.005 | 0.699 | GABA A receptor antagonist | 0.651 0.003 DB14028 0.699 0.003 DBMET00246 0.558 0.003 DBMET00980 | DBMET00246 | |
| 0.216 | 0.024 | 0.216 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET00246 | ||
| 0.243 | 0.053 | 0.577 | Anesthetic general | 0.345 0.025 DB14028 0.577 0.005 DBMET00246 0.371 0.02 DBMET00980 | DBMET00246 | |
| 0.202 | 0.014 | 0.227 | Potassium channel (Ca-activated) activator | 0.166 0.023 DB14028 0.096 0.059 DBMET00246 0.227 0.01 DBMET00980 | DBMET00980 | |
| 0.19 | 0.004 | 0.19 | Kainate receptor antagonist | 0.052 0.02 DB14028 0.081 0.01 DBMET00246 0.045 0.024 DBMET00980 | ||
| 0.187 | 0.005 | 0.187 | AMPA receptor antagonist | 0.103 0.011 DB14028 0.078 0.018 DBMET00246 0.091 0.014 DBMET00980 | ||
| 0.274 | 0.098 | 0.274 | Immunomodulator | |||
| 0.198 | 0.036 | 0.198 | Neurotensin receptor agonist | 0.166 0.068 DB14028 0.142 0.122 DBMET00246 0.192 0.039 DBMET00980 | ||
| 0.197 | 0.037 | 0.254 | Death-associated protein kinase 2 inhibitor | 0.254 0.012 DB14028 0.246 0.014 DBMET00246 0.249 0.014 DBMET00980 | DB14028 | |
| 0.161 | 0.005 | 0.161 | NMDA receptor subunit 3A antagonist | 0.08 0.012 DB14028 0.137 0.005 DBMET00980 | ||
| 0.159 | 0.003 | 0.159 | Kainate receptor 2 antagonist | 0.073 0.008 DB14028 0.047 0.018 DBMET00246 0.05 0.016 DBMET00980 | ||
| 0.255 | 0.102 | 0.458 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.326 0.048 DB14028 0.458 0.012 DBMET00246 0.302 0.063 DBMET00980 | DBMET00246 | |
| 0.191 | 0.039 | 0.191 | Catenin beta inhibitor | 0.165 0.074 DB14028 0.147 0.114 DBMET00246 0.189 0.042 DBMET00980 | ||
| 0.195 | 0.046 | 0.195 | Diuretic | 0.14 0.086 DB14028 0.117 0.108 DBMET00980 | ||
| 0.153 | 0.005 | 0.153 | Cholecystokinin antagonist | 0.089 0.01 DB14028 0.116 0.007 DBMET00246 0.054 0.022 DBMET00980 | ||
| 0.224 | 0.078 | 0.526 | Cyclic AMP phosphodiesterase inhibitor | 0.514 0.006 DB14028 0.226 0.077 DBMET00246 0.526 0.005 DBMET00980 | DBMET00980 | |
| 0.154 | 0.008 | 0.175 | Bromodomain-containing protein 2 inhibitor | 0.175 0.005 DB14028 0.103 0.037 DBMET00246 0.146 0.01 DBMET00980 | DB14028 | |
| 0.231 | 0.087 | 0.365 | Aryl hydrocarbon receptor agonist | 0.365 0.045 DB14028 0.264 0.073 DBMET00246 0.362 0.045 DBMET00980 | DB14028 | |
| 0.172 | 0.03 | 0.172 | Ferrochelatase inhibitor | 0.142 0.041 DB14028 0.099 0.072 DBMET00246 | ||
| 0.259 | 0.119 | 0.259 | Antithrombotic | |||
| 0.19 | 0.057 | 0.19 | Succinate dehydrogenase inhibitor | 0.151 0.111 DB14028 0.151 0.11 DBMET00246 0.162 0.092 DBMET00980 | ||
| 0.142 | 0.009 | 0.156 | Glycine receptor antagonist | 0.156 0.006 DB14028 0.146 0.008 DBMET00246 0.135 0.012 DBMET00980 | DB14028 | |
| 0.205 | 0.081 | 0.258 | Nitric-oxide synthase stimulant | 0.236 0.043 DB14028 0.206 0.079 DBMET00246 0.258 0.027 DBMET00980 | DBMET00980 | |
| 0.138 | 0.017 | 0.138 | Hematopoietic | |||
| 0.152 | 0.03 | 0.192 | Protein kinase C gamma inhibitor | 0.141 0.037 DB14028 0.192 0.016 DBMET00246 0.147 0.033 DBMET00980 | DBMET00246 | |
| 0.172 | 0.053 | 0.172 | Thiol protease inhibitor | 0.167 0.056 DB14028 0.135 0.087 DBMET00980 | ||
| 0.121 | 0.007 | 0.143 | GABA B receptor agonist | 0.113 0.009 DB14028 0.097 0.019 DBMET00246 0.143 0.005 DBMET00980 | DBMET00980 | |
| 0.137 | 0.025 | 0.155 | Electrolyte absorption antagonist | 0.111 0.044 DB14028 0.155 0.018 DBMET00246 0.088 0.079 DBMET00980 | DBMET00246 | |
| 0.115 | 0.004 | 0.123 | MDM2 inhibitor | 0.123 0.004 DB14028 0.087 0.013 DBMET00246 0.107 0.005 DBMET00980 | DB14028 | |
| 0.115 | 0.004 | 0.115 | AMPA 4 receptor antagonist | 0.044 0.021 DB14028 0.036 0.034 DBMET00246 0.044 0.021 DBMET00980 | ||
| 0.111 | 0.004 | 0.111 | Kainate receptor 1 antagonist | 0.022 0.014 DB14028 | ||
| 0.157 | 0.05 | 0.182 | MAP kinase kinase 4 inhibitor | 0.165 0.038 DB14028 0.158 0.048 DBMET00246 0.182 0.023 DBMET00980 | DBMET00980 | |
| 0.127 | 0.021 | 0.127 | Somatostatin 1 agonist | |||
| 0.111 | 0.005 | 0.111 | AMPA 1 receptor antagonist | 0.032 0.019 DB14028 0.032 0.019 DBMET00980 | ||
| 0.117 | 0.011 | 0.117 | NMDA 2C receptor antagonist | 0.076 0.028 DB14028 0.093 0.018 DBMET00980 | ||
| 0.149 | 0.048 | 0.149 | Heat shock protein 70 antagonist | 0.131 0.115 DBMET00980 | ||
| 0.219 | 0.118 | 0.244 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 DB14028 0.192 0.168 DBMET00246 0.237 0.094 DBMET00980 | DB14028 | |
| 0.14 | 0.043 | 0.14 | Sphingosine 1-phosphate receptor 4 antagonist | 0.134 0.051 DB14028 0.12 0.073 DBMET00980 | ||
| 0.262 | 0.166 | 0.262 | Antibacterial | |||
| 0.132 | 0.035 | 0.165 | Beta glucuronidase inhibitor | 0.117 0.048 DB14028 0.165 0.019 DBMET00246 0.159 0.021 DBMET00980 | DBMET00246 | |
| 0.179 | 0.083 | 0.179 | Platelet adhesion inhibitor | |||
| 0.2 | 0.105 | 0.41 | Aldehyde oxidase inhibitor | 0.199 0.105 DB14028 0.161 0.129 DBMET00246 0.41 0.045 DBMET00980 | DBMET00980 | |
| 0.137 | 0.044 | 0.218 | Interleukin 8 antagonist | 0.201 0.012 DB14028 0.218 0.009 DBMET00246 0.216 0.009 DBMET00980 | DBMET00246 | |
| 0.151 | 0.059 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DB14028 | ||
| 0.102 | 0.013 | 0.102 | Bromodomain-containing protein 4 inhibitor | 0.049 0.048 DB14028 | ||
| 0.102 | 0.013 | 0.102 | NMDA 2A receptor antagonist | 0.049 0.038 DB14028 0.075 0.022 DBMET00980 | ||
| 0.114 | 0.026 | 0.124 | NMDA 2 receptor antagonist | 0.07 0.051 DB14028 0.124 0.023 DBMET00980 | DBMET00980 | |
| 0.208 | 0.122 | 0.276 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.102 DB14028 0.188 0.159 DBMET00246 0.276 0.047 DBMET00980 | DBMET00980 | |
| 0.114 | 0.028 | 0.114 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.091 0.048 DB14028 0.082 0.061 DBMET00246 0.102 0.037 DBMET00980 | ||
| 0.09 | 0.006 | 0.09 | Bromodomain-containing protein 3 inhibitor | 0.066 0.015 DB14028 0.048 0.037 DBMET00246 0.052 0.03 DBMET00980 | ||
| 0.105 | 0.021 | 0.115 | Potassium channel large-conductance Ca-activated activator | 0.084 0.032 DB14028 0.061 0.058 DBMET00246 0.115 0.018 DBMET00980 | DBMET00980 | |
| 0.241 | 0.158 | 0.352 | Calcium channel activator | 0.352 0.048 DB14028 0.337 0.059 DBMET00980 | DB14028 | |
| 0.09 | 0.007 | 0.09 | Dihydroorotase inhibitor | |||
| 0.179 | 0.097 | 0.179 | Interleukin antagonist | 0.172 0.102 DBMET00980 | ||
| 0.095 | 0.014 | 0.095 | Phosphorylase inhibitor | 0.062 0.024 DB14028 0.066 0.022 DBMET00246 0.067 0.021 DBMET00980 | ||
| 0.12 | 0.041 | 0.195 | Creatine kinase inhibitor | 0.117 0.043 DB14028 0.106 0.053 DBMET00246 0.195 0.011 DBMET00980 | DBMET00980 | |
| 0.087 | 0.007 | 0.087 | Factor XIa inhibitor | 0.06 0.013 DB14028 0.039 0.03 DBMET00980 | ||
| 0.089 | 0.01 | 0.097 | Cholecystokinin A antagonist | 0.097 0.009 DB14028 0.051 0.019 DBMET00980 | DB14028 | |
| 0.104 | 0.027 | 0.197 | Cyclin B3 inhibitor | 0.154 0.013 DB14028 0.197 0.006 DBMET00246 0.148 0.014 DBMET00980 | DBMET00246 | |
| 0.149 | 0.073 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.14 0.092 DB14028 0.127 0.124 DBMET00246 0.141 0.091 DBMET00980 | ||
| 0.077 | 0.006 | 0.077 | Cholecystokinin B antagonist | 0.061 0.008 DBMET00246 | ||
| 0.075 | 0.005 | 0.185 | Benzodiazepine antagonist | 0.185 0.003 DB14028 0.133 0.003 DBMET00246 0.099 0.004 DBMET00980 | DB14028 | |
| 0.147 | 0.08 | 0.384 | Peroxidase inhibitor | 0.167 0.07 DB14028 0.172 0.068 DBMET00246 0.384 0.023 DBMET00980 | DBMET00980 | |
| 0.122 | 0.057 | 0.19 | Cystathionine beta-synthase inhibitor | 0.101 0.075 DB14028 0.108 0.068 DBMET00246 0.19 0.027 DBMET00980 | DBMET00980 | |
| 0.171 | 0.106 | 0.337 | Platelet aggregation inhibitor | 0.337 0.028 DB14028 0.249 0.052 DBMET00980 | DB14028 | |
| 0.116 | 0.052 | 0.116 | GABA C receptor agonist | |||
| 0.19 | 0.13 | 0.357 | 5 Hydroxytryptamine release stimulant | 0.354 0.055 DB14028 0.181 0.139 DBMET00246 0.357 0.055 DBMET00980 | DBMET00980 | |
| 0.103 | 0.045 | 0.283 | Potassium channel activator | 0.161 0.016 DB14028 0.283 0.005 DBMET00246 0.141 0.023 DBMET00980 | DBMET00246 | |
| 0.06 | 0.006 | 0.06 | AMPA 3 receptor antagonist | |||
| 0.058 | 0.005 | 0.234 | Benzodiazepine receptor peripheral-type antagonist | 0.079 0.004 DB14028 0.234 0.002 DBMET00246 0.059 0.005 DBMET00980 | DBMET00246 | |
| 0.137 | 0.085 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.131 0.112 DB14028 0.129 0.124 DBMET00246 0.131 0.116 DBMET00980 | ||
| 0.141 | 0.089 | 0.141 | Thrombolytic | |||
| 0.057 | 0.006 | 0.057 | NMDA 2D receptor antagonist | |||
| 0.057 | 0.008 | 0.057 | Factor XI inhibitor | 0.045 0.012 DB14028 0.037 0.019 DBMET00246 0.031 0.029 DBMET00980 | ||
| 0.062 | 0.014 | 0.391 | Purinergic P2X4 antagonist | 0.355 0.002 DB14028 0.079 0.007 DBMET00246 0.391 0.002 DBMET00980 | DBMET00980 | |
| 0.06 | 0.014 | 0.06 | Glutamate (mGluR4) antagonist | |||
| 0.111 | 0.065 | 0.21 | Polo-like kinase-4 inhibitor | 0.21 0.014 DB14028 0.173 0.024 DBMET00980 | DB14028 | |
| 0.147 | 0.103 | 0.184 | Cyclin-dependent kinase 3 inhibitor | 0.183 0.046 DB14028 0.17 0.06 DBMET00246 0.184 0.045 DBMET00980 | DBMET00980 | |
| 0.108 | 0.065 | 0.132 | Nav1.4 sodium channel blocker | 0.12 0.052 DB14028 0.094 0.086 DBMET00246 0.132 0.043 DBMET00980 | DBMET00980 | |
| 0.157 | 0.114 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.148 0.122 DB14028 0.137 0.132 DBMET00980 | ||
| 0.051 | 0.008 | 0.051 | Glutamate (mGluR8) antagonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | |||
| 0.093 | 0.052 | 0.094 | NADH dehydrogenase inhibitor | 0.082 0.071 DB14028 0.094 0.051 DBMET00246 0.088 0.059 DBMET00980 | DBMET00246 | |
| 0.102 | 0.062 | 0.102 | Protein kinase (CK2) inhibitor | 0.087 0.075 DBMET00980 | ||
| 0.135 | 0.095 | 0.167 | MAP kinase 3 inhibitor | 0.145 0.075 DB14028 0.167 0.046 DBMET00246 | DBMET00246 | |
| 0.047 | 0.008 | 0.047 | Kainate receptor 4 antagonist | 0.024 0.018 DB14028 | ||
| 0.055 | 0.015 | 0.147 | GABA B receptor antagonist | 0.147 0.004 DB14028 0.053 0.017 DBMET00246 0.124 0.004 DBMET00980 | DB14028 | |
| 0.076 | 0.037 | 0.088 | Protein kinase C beta inhibitor | 0.075 0.038 DB14028 0.088 0.021 DBMET00246 0.075 0.038 DBMET00980 | DBMET00246 | |
| 0.111 | 0.073 | 0.133 | Sphingosine 1-phosphate receptor 2 agonist | 0.133 0.039 DB14028 0.104 0.09 DBMET00246 0.124 0.048 DBMET00980 | DB14028 | |
| 0.044 | 0.006 | 0.044 | Kainate receptor 5 antagonist | |||
| 0.046 | 0.008 | 0.046 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.077 | 0.04 | 0.087 | Phenylalanine 4-hydroxylase inhibitor | 0.087 0.033 DBMET00980 | DBMET00980 | |
| 0.091 | 0.054 | 0.091 | Interleukin 5 antagonist | |||
| 0.093 | 0.056 | 0.093 | Triose-phosphate isomerase inhibitor | |||
| 0.049 | 0.013 | 0.049 | Glutamate (mGluR3) antagonist | |||
| 0.06 | 0.028 | 0.06 | Adenine nucleotide translocase inhibitor | |||
| 0.06 | 0.028 | 0.06 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.115 | 0.083 | 0.115 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.048 | 0.016 | 0.048 | Kainate receptor agonist | |||
| 0.047 | 0.016 | 0.053 | p53 inhibitor | 0.053 0.012 DB14028 0.037 0.022 DBMET00980 | DB14028 | |
| 0.079 | 0.05 | 0.106 | MAP kinase kinase 7 inhibitor | 0.085 0.035 DB14028 0.078 0.053 DBMET00246 0.106 0.008 DBMET00980 | DBMET00980 | |
| 0.069 | 0.041 | 0.069 | Glutamate (mGluR6) antagonist | |||
| 0.043 | 0.017 | 0.043 | Integrin alpha2 antagonist | |||
| 0.124 | 0.097 | 0.141 | Aurora-C kinase inhibitor | 0.141 0.062 DB14028 0.122 0.1 DBMET00246 0.13 0.083 DBMET00980 | DB14028 | |
| 0.046 | 0.022 | 0.046 | Somatostatin 1 antagonist | |||
| 0.078 | 0.054 | 0.089 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 DBMET00980 | DBMET00980 | |
| 0.033 | 0.01 | 0.033 | Integrin alpha2beta1 antagonist | |||
| 0.049 | 0.027 | 0.075 | Benzodiazepine inverse agonist | 0.075 0.008 DB14028 0.049 0.027 DBMET00246 0.057 0.017 DBMET00980 | DB14028 | |
| 0.044 | 0.022 | 0.058 | Acid-sensing ion channel blocker | 0.058 0.01 DB14028 0.042 0.025 DBMET00246 0.052 0.014 DBMET00980 | DB14028 | |
| 0.038 | 0.015 | 0.038 | AMPA 2 receptor antagonist | |||
| 0.071 | 0.05 | 0.097 | Phospholipase D inhibitor | 0.097 0.016 DB14028 0.066 0.063 DBMET00246 0.076 0.042 DBMET00980 | DB14028 | |
| 0.069 | 0.049 | 0.084 | Prostaglandin-E synthase inhibitor | 0.084 0.036 DB14028 0.074 0.044 DBMET00980 | DB14028 | |
| 0.116 | 0.096 | 0.116 | Histone deacetylase SIRT1 inhibitor | |||
| 0.088 | 0.068 | 0.186 | Protein kinase C zeta inhibitor | 0.124 0.03 DB14028 0.186 0.013 DBMET00246 0.158 0.018 DBMET00980 | DBMET00246 | |
| 0.051 | 0.034 | 0.051 | Antiviral (Hepatitis D) | |||
| 0.164 | 0.146 | 0.227 | ErbB-1 antagonist | 0.226 0.066 DB14028 0.175 0.124 DBMET00246 0.227 0.065 DBMET00980 | DBMET00980 | |
| 0.087 | 0.07 | 0.087 | Glutamate release inhibitor | 0.086 0.071 DB14028 | ||
| 0.023 | 0.007 | 0.023 | Kainate receptor 3 antagonist | |||
| 0.089 | 0.074 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 DB14028 0.096 0.062 DBMET00246 0.106 0.047 DBMET00980 | DB14028 | |
| 0.035 | 0.021 | 0.035 | Somatostatin 5 antagonist | |||
| 0.034 | 0.021 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.033 0.023 DB14028 0.035 0.019 DBMET00980 | DBMET00980 | |
| 0.122 | 0.109 | 0.122 | Hemostatic | |||
| 0.055 | 0.043 | 0.059 | Pregnane X receptor antagonist | 0.059 0.033 DB14028 0.058 0.035 DBMET00980 | DB14028 | |
| 0.08 | 0.068 | 0.097 | D-Ala-D-Ala ligase inhibitor | 0.078 0.074 DB14028 0.081 0.067 DBMET00246 0.097 0.033 DBMET00980 | DBMET00980 | |
| 0.083 | 0.074 | 0.121 | HIV-1 integrase (Overall Integration) inhibitor | 0.11 0.046 DB14028 0.121 0.039 DBMET00980 | DBMET00980 | |
| 0.066 | 0.062 | 0.066 | Glycine receptor agonist | |||
| 0.108 | 0.104 | 0.136 | Alkaline phosphatase inhibitor | 0.136 0.07 DBMET00980 | DBMET00980 | |
| 0.011 | 0.008 | 0.011 | CD80 antagonist | 0.011 0.008 DB14028 | ||
| 0.057 | 0.055 | 0.136 | Phosphodiesterase III inhibitor | 0.136 0.012 DB14028 0.12 0.015 DBMET00980 | DB14028 | |
| 0.141 | 0.14 | 0.417 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.417 0.014 DB14028 0.322 0.03 DBMET00246 0.352 0.023 DBMET00980 | DB14028 | |
| 0.08 | 0.079 | 0.08 | Alcohol dehydrogenase inhibitor | |||
| 0.095 | 0.101 | 0.121 | Amylase inhibitor | 0.121 0.081 DBMET00980 | DBMET00980 | |
| 0.094 | 0.101 | 0.1 | Photosensitizer | 0.098 0.093 DB14028 0.1 0.089 DBMET00980 | DBMET00980 | |
| 0.09 | 0.099 | 0.109 | DOPA decarboxylase inhibitor | 0.109 0.059 DBMET00980 | DBMET00980 | |
| 0.035 | 0.046 | 0.138 | Phosphodiesterase 3B inhibitor | 0.138 0.006 DB14028 0.129 0.007 DBMET00980 | DB14028 | |
| 0.074 | 0.086 | 0.08 | mTOR complex 2 inhibitor | 0.08 0.069 DB14028 | DB14028 | |
| 0.08 | 0.092 | 0.113 | Carbonic anhydrase III inhibitor | 0.113 0.05 DBMET00980 | DBMET00980 | |
| 0.037 | 0.054 | 0.056 | Alpha 1L adrenoreceptor agonist | 0.056 0.011 DB14028 0.041 0.036 DBMET00246 0.047 0.02 DBMET00980 | DB14028 | |
| 0.098 | 0.116 | 0.159 | NADPH oxidase inhibitor | 0.121 0.082 DB14028 0.159 0.049 DBMET00980 | DBMET00980 | |
| 0.042 | 0.061 | 0.079 | Cyclin B2 inhibitor | 0.063 0.028 DB14028 0.079 0.015 DBMET00246 0.064 0.027 DBMET00980 | DBMET00246 | |
| 0.041 | 0.062 | 0.082 | Protein kinase C eta inhibitor | 0.082 0.023 DBMET00246 0.05 0.044 DBMET00980 | DBMET00246 | |
| 0.045 | 0.07 | 0.086 | 5 Hydroxytryptamine 7 agonist | 0.086 0.01 DB14028 0.077 0.014 DBMET00980 | DB14028 | |
| 0.037 | 0.062 | 0.046 | Parathyroid hormone antagonist | 0.046 0.028 DB14028 | DB14028 | |
| 0.043 | 0.068 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.023 DB14028 | DB14028 | |
| 0.081 | 0.106 | 0.102 | AMP-activated protein kinase stimulant | 0.102 0.067 DBMET00980 | DBMET00980 | |
| 0.05 | 0.077 | 0.109 | Corticotropin releasing factor 2 receptor antagonist | 0.109 0.005 DB14028 0.074 0.024 DBMET00980 | DB14028 | |
| 0.112 | 0.14 | 0.161 | Polo-like kinase-3 inhibitor | 0.161 0.073 DB14028 0.133 0.105 DBMET00980 | DB14028 | |
| 0.033 | 0.063 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.021 DBMET00980 | DBMET00980 | |
| 0.109 | 0.139 | 0.158 | Mcl-1 antagonist | 0.158 0.082 DBMET00980 | DBMET00980 | |
| 0.089 | 0.12 | 0.126 | Aldehyde dehydrogenase inhibitor | 0.126 0.065 DBMET00980 | DBMET00980 | |
| 0.073 | 0.105 | 0.09 | Polo-like kinase-1 inhibitor | 0.09 0.062 DB14028 | DB14028 | |
| 0.078 | 0.11 | 0.22 | 5 Hydroxytryptamine 3A agonist | 0.22 0.01 DB14028 0.116 0.059 DBMET00246 0.201 0.015 DBMET00980 | DB14028 | |
| 0.037 | 0.071 | 0.125 | Glutamate (mGluR1) antagonist | 0.125 0.01 DB14028 0.075 0.026 DBMET00980 | DB14028 | |
| 0.024 | 0.058 | 0.046 | Estrogen-related receptor beta antagonist | 0.046 0.007 DBMET00980 | DBMET00980 | |
| 0.124 | 0.158 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.1 DB14028 | DB14028 | |
| 0.056 | 0.092 | 0.082 | Adenosine A3 receptor antagonist | 0.082 0.04 DB14028 0.073 0.054 DBMET00980 | DB14028 | |
| 0.019 | 0.057 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 DB14028 0.024 0.023 DBMET00246 | DB14028 | |
| 0.093 | 0.131 | 0.108 | Transcription factor STAT6 inhibitor | 0.108 0.086 DBMET00980 | DBMET00980 | |
| 0.106 | 0.144 | 0.13 | MAP3K9 inhibitor | 0.13 0.094 DB14028 0.126 0.102 DBMET00246 0.13 0.095 DBMET00980 | DBMET00980 | |
| 0.038 | 0.076 | 0.073 | Cyclin B inhibitor | 0.056 0.036 DB14028 0.073 0.019 DBMET00246 0.058 0.035 DBMET00980 | DBMET00246 | |
| 0.04 | 0.083 | 0.079 | Cyclin B1 inhibitor | 0.063 0.039 DB14028 0.079 0.023 DBMET00246 0.065 0.038 DBMET00980 | DBMET00246 | |
| 0.051 | 0.096 | 0.063 | Kallikrein 7 inhibitor | 0.063 0.046 DBMET00246 | DBMET00246 | |
| 0.038 | 0.085 | 0.053 | Androgen agonist | 0.053 0.052 DBMET00980 | DBMET00980 | |
| 0.044 | 0.093 | 0.061 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.04 DB14028 | DB14028 | |
| 0.113 | 0.163 | 0.214 | MAP kinase kinase 2 inhibitor | 0.214 0.073 DB14028 0.203 0.08 DBMET00980 | DB14028 | |
| 0.05 | 0.102 | 0.067 | MAP-kinase-activated kinase 2 inhibitor | 0.067 0.063 DB14028 | DB14028 | |
| 0.143 | 0.2 | 0.176 | Superoxide dismutase inhibitor | 0.176 0.147 DBMET00980 | DBMET00980 | |
| 0.056 | 0.116 | 0.074 | MAP-kinase-activated kinase inhibitor | 0.074 0.072 DB14028 | DB14028 | |
| 0.044 | 0.105 | 0.076 | Aryl hydrocarbon receptor antagonist | 0.076 0.031 DB14028 0.069 0.039 DBMET00980 | DB14028 | |
| 0.178 | 0.239 | 0.229 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.229 0.097 DB14028 0.204 0.155 DBMET00246 0.197 0.175 DBMET00980 | DB14028 | |
| 0.123 | 0.184 | 0.17 | Immunostimulant | 0.17 0.139 DBMET00980 | DBMET00980 | |
| 0.033 | 0.094 | 0.056 | Pim-2 kinase inhibitor | 0.056 0.035 DB14028 | DB14028 | |
| 0.105 | 0.168 | 0.153 | Pyruvate kinase inhibitor | 0.153 0.112 DBMET00980 | DBMET00980 | |
| 0.122 | 0.187 | 0.23 | Neurotrophic factor enhancer | 0.178 0.101 DB14028 0.23 0.051 DBMET00980 | DBMET00980 | |
| 0.022 | 0.088 | 0.04 | CDK5/p25 inhibitor | 0.039 0.031 DB14028 0.04 0.029 DBMET00980 | DBMET00980 | |
| 0.2 | 0.27 | 0.297 | MAP kinase kinase 6 inhibitor | 0.297 0.138 DB14028 0.226 0.225 DBMET00246 0.236 0.209 DBMET00980 | DB14028 | |
| 0.046 | 0.117 | 0.067 | I kappa B kinase 1 inhibitor | 0.067 0.053 DB14028 | DB14028 | |
| 0.035 | 0.106 | 0.074 | Cyclin D1 inhibitor | 0.074 0.023 DB14028 0.056 0.05 DBMET00246 0.071 0.027 DBMET00980 | DB14028 | |
| 0.106 | 0.179 | 0.152 | Pregnane X receptor agonist | 0.152 0.049 DB14028 0.144 0.065 DBMET00980 | DB14028 | |
| 0.077 | 0.151 | 0.137 | Cytokine production inhibitor | 0.137 0.073 DB14028 | DB14028 | |
| 0.042 | 0.117 | 0.073 | Phosphodiesterase 1A inhibitor | 0.073 0.021 DB14028 0.056 0.051 DBMET00980 | DB14028 | |
| 0.014 | 0.094 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.005 DBMET00246 | DBMET00246 | |
| 0.009 | 0.091 | 0.038 | Cyclin E2 inhibitor | 0.028 0.021 DB14028 0.038 0.013 DBMET00246 | DBMET00246 | |
| 0.048 | 0.132 | 0.098 | Histamine N-methyltransferase inhibitor | 0.098 0.048 DB14028 0.088 0.058 DBMET00980 | DB14028 | |
| 0.044 | 0.129 | 0.06 | Phosphodiesterase 1C inhibitor | 0.06 0.048 DB14028 | DB14028 | |
| 0.095 | 0.182 | 0.203 | LIM domain kinase 1 inhibitor | 0.203 0.061 DB14028 0.165 0.084 DBMET00980 | DB14028 | |
| 0.084 | 0.17 | 0.284 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.151 0.088 DB14028 0.284 0.037 DBMET00246 0.123 0.113 DBMET00980 | DBMET00246 | |
| 0.043 | 0.132 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 DBMET00980 | DBMET00980 | |
| 0.04 | 0.13 | 0.086 | Protein kinase B beta inhibitor | 0.078 0.044 DB14028 0.086 0.036 DBMET00246 | DBMET00246 | |
| 0.108 | 0.199 | 0.142 | Death-associated protein kinase 3 inhibitor | 0.142 0.136 DB14028 | DB14028 | |
| 0.129 | 0.222 | 0.234 | 5 Hydroxytryptamine 1E antagonist | 0.234 0.093 DB14028 0.223 0.105 DBMET00980 | DB14028 | |
| 0.101 | 0.196 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.132 0.076 DB14028 0.124 0.101 DBMET00246 0.122 0.105 DBMET00980 | DB14028 | |
| 0.023 | 0.118 | 0.053 | 5 Hydroxytryptamine 2B agonist | 0.053 0.012 DB14028 0.036 0.034 DBMET00980 | DB14028 | |
| 0.076 | 0.172 | 0.113 | CDC-like kinase 1 inhibitor | 0.111 0.106 DB14028 0.113 0.102 DBMET00980 | DBMET00980 | |
| 0.059 | 0.155 | 0.166 | DNA directed RNA polymerase inhibitor | 0.166 0.02 DB14028 0.133 0.03 DBMET00980 | DB14028 | |
| 0.191 | 0.288 | 0.271 | Apoptosis agonist | 0.271 0.194 DBMET00980 | DBMET00980 | |
| 0.05 | 0.148 | 0.113 | GABA A receptor agonist | 0.113 0.028 DB14028 0.085 0.055 DBMET00980 | DB14028 | |
| 0.049 | 0.147 | 0.088 | Urease inhibitor | 0.088 0.08 DBMET00980 | DBMET00980 | |
| 0.03 | 0.132 | 0.094 | Cannabinoid CB1 receptor antagonist | 0.094 0.019 DB14028 0.058 0.048 DBMET00980 | DB14028 | |
| 0.099 | 0.202 | 0.23 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.181 0.105 DB14028 0.23 0.076 DBMET00980 | DBMET00980 | |
| 0.03 | 0.133 | 0.067 | CDC7 inhibitor | 0.067 0.047 DB14028 | DB14028 | |
| 0.062 | 0.165 | 0.086 | MAP kinase kinase 1 inhibitor | 0.086 0.076 DB14028 | DB14028 | |
| 0.036 | 0.143 | 0.058 | Potassium channel (Ca-activated) blocker | 0.058 0.046 DB14028 | DB14028 | |
| 0.037 | 0.146 | 0.082 | Topoisomerase II alpha inhibitor | 0.082 0.052 DBMET00980 | DBMET00980 | |
| 0.108 | 0.218 | 0.203 | Spasmolytic | 0.183 0.134 DB14028 0.203 0.116 DBMET00980 | DBMET00980 | |
| 0.126 | 0.236 | 0.252 | MAP-kinase-activated kinase 5 inhibitor | 0.192 0.114 DB14028 0.252 0.058 DBMET00246 0.193 0.112 DBMET00980 | DBMET00246 | |
| 0.1 | 0.211 | 0.278 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.278 0.049 DB14028 0.161 0.102 DBMET00246 0.202 0.074 DBMET00980 | DB14028 | |
| 0.076 | 0.188 | 0.112 | Interleukin 1 antagonist | 0.112 0.101 DB14028 0.109 0.106 DBMET00980 | DB14028 | |
| 0.035 | 0.148 | 0.084 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.084 0.048 DBMET00980 | DBMET00980 | |
| 0.056 | 0.171 | 0.216 | Glycogen synthase kinase-3 alpha inhibitor | 0.216 0.037 DB14028 0.209 0.039 DBMET00980 | DB14028 | |
| 0.05 | 0.166 | 0.07 | Vanilloid 4 agonist | 0.07 0.066 DB14028 | DB14028 | |
| 0.056 | 0.172 | 0.133 | EphA2 antagonist | 0.133 0.042 DB14028 0.103 0.072 DBMET00980 | DB14028 | |
| 0.027 | 0.144 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.038 DB14028 | DB14028 | |
| 0.025 | 0.143 | 0.082 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DB14028 0.078 0.029 DBMET00980 | DB14028 | |
| 0.028 | 0.148 | 0.048 | Potassium channel (Inward rectifier) activator | 0.048 0.039 DB14028 | DB14028 | |
| 0.087 | 0.207 | 0.175 | Heat shock protein 90 alpha antagonist | 0.175 0.066 DBMET00980 | DBMET00980 | |
| 0.01 | 0.13 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.025 DB14028 | DB14028 | |
| 0.138 | 0.258 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.149 DB14028 0.181 0.157 DBMET00980 | DB14028 | |
| 0.031 | 0.153 | 0.052 | Sodium/calcium exchanger inhibitor | 0.052 0.03 DB14028 | DB14028 | |
| 0.093 | 0.218 | 0.224 | Dyrk kinase inhibitor | 0.177 0.112 DB14028 0.224 0.085 DBMET00980 | DBMET00980 | |
| 0.051 | 0.179 | 0.095 | Phosphodiesterase I inhibitor | 0.095 0.051 DB14028 0.087 0.063 DBMET00980 | DB14028 | |
| 0.032 | 0.161 | 0.062 | Phosphodiesterase 1B inhibitor | 0.062 0.04 DB14028 | DB14028 | |
| 0.018 | 0.148 | 0.088 | Plasminogen activator inhibitor | 0.088 0.021 DBMET00246 | DBMET00246 | |
| 0.055 | 0.185 | 0.093 | Adenylate cyclase inhibitor | 0.093 0.091 DBMET00980 | DBMET00980 | |
| 0.021 | 0.152 | 0.047 | Histamine H1 receptor agonist | 0.047 0.023 DB14028 | DB14028 | |
| 0.095 | 0.226 | 0.15 | CF transmembrane conductance regulator agonist | 0.15 0.075 DBMET00980 | DBMET00980 | |
| 0.035 | 0.169 | 0.322 | Glutamate (mGluR) antagonist | 0.322 0.005 DB14028 0.202 0.01 DBMET00980 | DB14028 | |
| 0.029 | 0.163 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.041 DBMET00980 | DBMET00980 | |
| 0.034 | 0.171 | 0.062 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.041 DB14028 | DB14028 | |
| 0.025 | 0.165 | 0.051 | Histamine H4 receptor antagonist | 0.051 0.029 DB14028 | DB14028 | |
| 0.02 | 0.164 | 0.055 | Phosphodiesterase 4C inhibitor | 0.055 0.04 DB14028 | DB14028 | |
| 0.034 | 0.178 | 0.068 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.068 0.03 DBMET00980 | DBMET00980 | |
| 0.045 | 0.191 | 0.131 | Topoisomerase II inhibitor | 0.131 0.059 DBMET00980 | DBMET00980 | |
| 0.036 | 0.183 | 0.105 | Phosphodiesterase 3A inhibitor | 0.105 0.029 DB14028 0.093 0.039 DBMET00980 | DB14028 | |
| 0.053 | 0.2 | 0.119 | MAP kinase 12 inhibitor | 0.119 0.072 DB14028 0.109 0.084 DBMET00246 | DB14028 | |
| 0.03 | 0.178 | 0.057 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 DB14028 | DB14028 | |
| 0.137 | 0.287 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.061 DB14028 | DB14028 | |
| 0.025 | 0.176 | 0.094 | Cannabinoid receptor antagonist | 0.094 0.031 DB14028 | DB14028 | |
| 0.063 | 0.214 | 0.117 | Nav1.2 sodium channel blocker | 0.117 0.087 DB14028 | DB14028 | |
| 0.06 | 0.212 | 0.123 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.123 0.082 DBMET00246 | DBMET00246 | |
| 0.036 | 0.187 | 0.072 | Protein kinase B gamma inhibitor | 0.072 0.055 DB14028 | DB14028 | |
| 0.02 | 0.172 | 0.056 | Adenylate cyclase 1 inhibitor | 0.056 0.02 DB14028 0.051 0.025 DBMET00980 | DB14028 | |
| 0.05 | 0.204 | 0.106 | MAP kinase 13 inhibitor | 0.106 0.072 DB14028 0.098 0.084 DBMET00246 | DB14028 | |
| 0.029 | 0.185 | 0.063 | 5 Hydroxytryptamine 3 agonist | 0.063 0.044 DB14028 | DB14028 | |
| 0.053 | 0.209 | 0.121 | MAP kinase kinase inhibitor | 0.108 0.086 DB14028 0.121 0.073 DBMET00980 | DBMET00980 | |
| 0.035 | 0.196 | 0.125 | Topoisomerase I inhibitor | 0.125 0.053 DBMET00980 | DBMET00980 | |
| 0.042 | 0.203 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 DBMET00246 | DBMET00246 | |
| 0.092 | 0.254 | 0.172 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.172 0.116 DB14028 | DB14028 | |
| 0.012 | 0.179 | 0.038 | Dopamine D5 agonist | 0.038 0.03 DBMET00980 | DBMET00980 | |
| 0.031 | 0.198 | 0.322 | Glutamate (mGluR group I) antagonist | 0.322 0.005 DB14028 0.198 0.008 DBMET00980 | DB14028 | |
| 0.038 | 0.21 | 0.182 | Platelet activating factor antagonist | 0.182 0.031 DB14028 0.112 0.069 DBMET00980 | DB14028 | |
| 0.122 | 0.294 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.147 DB14028 | DB14028 | |
| 0.027 | 0.199 | 0.071 | Nav1.7 sodium channel blocker | 0.071 0.043 DB14028 | DB14028 | |
| 0.023 | 0.199 | 0.069 | Dopamine D1 antagonist | 0.069 0.041 DBMET00980 | DBMET00980 | |
| 0.101 | 0.278 | 0.212 | DNA damaging | 0.191 0.123 DB14028 0.212 0.106 DBMET00246 0.2 0.115 DBMET00980 | DBMET00246 | |
| 0.036 | 0.215 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.059 DB14028 | DB14028 | |
| 0.011 | 0.191 | 0.176 | Phosphodiesterase 2A inhibitor | 0.176 0.005 DB14028 0.131 0.005 DBMET00980 | DB14028 | |
| 0.029 | 0.21 | 0.063 | Heat shock protein 90 beta antagonist | 0.063 0.036 DBMET00980 | DBMET00980 | |
| 0.018 | 0.199 | 0.081 | Phosphodiesterase VII inhibitor | 0.081 0.025 DB14028 0.056 0.052 DBMET00980 | DB14028 | |
| 0.01 | 0.195 | 0.188 | Phosphodiesterase II inhibitor | 0.188 0.005 DB14028 0.141 0.005 DBMET00980 | DB14028 | |
| 0.011 | 0.2 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.032 DB14028 | DB14028 | |
| 0.046 | 0.236 | 0.128 | Nav1.6 sodium channel blocker | 0.128 0.084 DB14028 | DB14028 | |
| 0.036 | 0.23 | 0.065 | Exportin-1 inhibitor | 0.065 0.055 DB14028 | DB14028 | |
| 0.068 | 0.268 | 0.173 | Cyclin-dependent kinase 8 inhibitor | 0.173 0.057 DB14028 0.143 0.086 DBMET00980 | DB14028 | |
| 0.046 | 0.251 | 0.183 | Sodium channel (voltage-gated) blocker | 0.183 0.036 DB14028 0.119 0.086 DBMET00980 | DB14028 | |
| 0.011 | 0.218 | 0.059 | Adenosine A2b receptor antagonist | 0.059 0.025 DB14028 | DB14028 | |
| 0.064 | 0.271 | 0.154 | Heat shock protein 90 antagonist | 0.154 0.07 DBMET00980 | DBMET00980 | |
| 0.036 | 0.248 | 0.142 | Protein kinase C mu inhibitor | 0.142 0.03 DBMET00246 | DBMET00246 | |
| 0.097 | 0.312 | 0.236 | Transcription factor NF kappa B inhibitor | 0.236 0.138 DBMET00980 | DBMET00980 | |
| 0.165 | 0.383 | 0.29 | Caspase 9 stimulant | 0.284 0.212 DBMET00246 0.29 0.205 DBMET00980 | DBMET00980 | |
| 0.071 | 0.293 | 0.161 | Interleukin 6 antagonist | 0.161 0.074 DBMET00246 | DBMET00246 | |
| 0.047 | 0.271 | 0.155 | Protein kinase C nu inhibitor | 0.155 0.067 DBMET00246 | DBMET00246 | |
| 0.039 | 0.267 | 0.073 | Estrogen receptor alpha antagonist | 0.073 0.061 DBMET00980 | DBMET00980 | |
| 0.066 | 0.296 | 0.529 | Sigma receptor agonist | 0.529 0.007 DB14028 0.498 0.01 DBMET00980 | DB14028 | |
| 0.032 | 0.265 | 0.096 | DNA intercalator | 0.093 0.081 DB14028 0.096 0.077 DBMET00980 | DBMET00980 | |
| 0.069 | 0.308 | 0.149 | Free radical scavenger | 0.149 0.147 DBMET00980 | DBMET00980 | |
| 0.034 | 0.283 | 0.101 | 5 Hydroxytryptamine 2B antagonist | 0.101 0.082 DB14028 | DB14028 | |
| 0.052 | 0.308 | 0.078 | CC chemokine 5 receptor agonist | 0.078 0.072 DBMET00980 | DBMET00980 | |
| 0.114 | 0.39 | 0.257 | Analgesic | 0.257 0.176 DB14028 0.233 0.199 DBMET00246 0.24 0.192 DBMET00980 | DB14028 | |
| 0.034 | 0.313 | 0.135 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.106 0.094 DB14028 0.135 0.07 DBMET00980 | DBMET00980 | |
| 0.017 | 0.297 | 0.112 | MAO A inhibitor | 0.112 0.057 DBMET00980 | DBMET00980 | |
| 0.011 | 0.292 | 0.051 | 5 Hydroxytryptamine 6 antagonist | 0.051 0.048 DB14028 | DB14028 | |
| 0.012 | 0.294 | 0.055 | Purinergic P2X antagonist | 0.055 0.027 DB14028 | DB14028 | |
| 0.075 | 0.374 | 0.308 | 12-Lipoxygenase inhibitor | 0.199 0.152 DB14028 0.308 0.075 DBMET00980 | DBMET00980 | |
| 0.032 | 0.336 | 0.11 | Alpha 2b adrenoreceptor antagonist | 0.11 0.066 DB14028 | DB14028 | |
| 0.032 | 0.337 | 0.16 | Phosphodiesterase inhibitor | 0.16 0.052 DB14028 0.115 0.088 DBMET00980 | DB14028 | |
| 0.041 | 0.354 | 0.097 | Nav1.1 sodium channel blocker | 0.097 0.07 DBMET00246 | DBMET00246 | |
| 0.012 | 0.331 | 0.062 | Purinergic P2 antagonist | 0.062 0.046 DB14028 | DB14028 | |
| 0.025 | 0.351 | 0.11 | Tubulin antagonist | 0.11 0.091 DBMET00980 | DBMET00980 | |
| 0.03 | 0.362 | 0.143 | Sodium channel blocker | 0.143 0.063 DB14028 | DB14028 | |
| 0.016 | 0.368 | 0.103 | MAO inhibitor | 0.103 0.087 DBMET00980 | DBMET00980 | |
| 0.027 | 0.392 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.046 DBMET00980 | DBMET00980 | |
| 0.006 | 0.376 | 0.203 | Glutamate (mGluR5) antagonist | 0.203 0.004 DB14028 0.113 0.008 DBMET00980 | DB14028 | |
| 0.034 | 0.412 | 0.119 | Estrogen antagonist | 0.119 0.056 DBMET00980 | DBMET00980 | |
| 0.037 | 0.491 | 0.178 | Antioxidant | 0.178 0.134 DBMET00246 | DBMET00246 | |
| 0.014 | 0.577 | 0.167 | Lipid peroxidase inhibitor | 0.167 0.057 DBMET00246 | DBMET00246 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |